DK3749673T3 - Krystallinsk form af bictegravir-natrium - Google Patents
Krystallinsk form af bictegravir-natrium Download PDFInfo
- Publication number
- DK3749673T3 DK3749673T3 DK19701843.5T DK19701843T DK3749673T3 DK 3749673 T3 DK3749673 T3 DK 3749673T3 DK 19701843 T DK19701843 T DK 19701843T DK 3749673 T3 DK3749673 T3 DK 3749673T3
- Authority
- DK
- Denmark
- Prior art keywords
- crystalline form
- bictegravir sodium
- bictegravir
- sodium
- crystalline
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- AIDS & HIV (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18156094 | 2018-02-09 | ||
| EP18194234 | 2018-09-13 | ||
| PCT/EP2019/051818 WO2019154634A1 (en) | 2018-02-09 | 2019-01-25 | Crystalline form of bictegravir sodium |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3749673T3 true DK3749673T3 (da) | 2022-06-20 |
Family
ID=65234570
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK19701843.5T DK3749673T3 (da) | 2018-02-09 | 2019-01-25 | Krystallinsk form af bictegravir-natrium |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP3749673B1 (da) |
| CN (1) | CN111699190A (da) |
| AU (1) | AU2019218837A1 (da) |
| BR (1) | BR112020015217A2 (da) |
| CA (1) | CA3088596C (da) |
| DK (1) | DK3749673T3 (da) |
| ES (1) | ES2916405T3 (da) |
| MX (1) | MX2020008360A (da) |
| SI (1) | SI3749673T1 (da) |
| WO (1) | WO2019154634A1 (da) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111978333B (zh) * | 2019-09-30 | 2021-06-18 | 常州制药厂有限公司 | Bictegravir钠盐的晶型A、制备方法及用途 |
| CN113698420A (zh) * | 2020-05-22 | 2021-11-26 | 上海迪赛诺生物医药有限公司 | 比克替拉韦钠的新晶型及其制备方法 |
| CN112409380A (zh) * | 2020-12-10 | 2021-02-26 | 上海迪赛诺生物医药有限公司 | 比克替拉韦钠的新晶型的制备方法及其应用 |
| US12187740B2 (en) | 2021-04-19 | 2025-01-07 | Honour Lab Limited | Polymorphic forms of bictegravir potassium |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ME02400B (me) | 2012-12-21 | 2016-09-20 | Gilead Sciences Inc | Policiklična karbamoilpiridonska jedinjenja i njihova farmaceutska upotreba |
| TW201613936A (en) * | 2014-06-20 | 2016-04-16 | Gilead Sciences Inc | Crystalline forms of(2R,5S,13aR)-8-hydroxy-7,9-dioxo-n-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide |
| NO2717902T3 (da) | 2014-06-20 | 2018-06-23 |
-
2019
- 2019-01-25 CA CA3088596A patent/CA3088596C/en active Active
- 2019-01-25 ES ES19701843T patent/ES2916405T3/es active Active
- 2019-01-25 EP EP19701843.5A patent/EP3749673B1/en active Active
- 2019-01-25 MX MX2020008360A patent/MX2020008360A/es unknown
- 2019-01-25 DK DK19701843.5T patent/DK3749673T3/da active
- 2019-01-25 WO PCT/EP2019/051818 patent/WO2019154634A1/en not_active Ceased
- 2019-01-25 AU AU2019218837A patent/AU2019218837A1/en not_active Abandoned
- 2019-01-25 BR BR112020015217-0A patent/BR112020015217A2/pt active Search and Examination
- 2019-01-25 SI SI201930241T patent/SI3749673T1/sl unknown
- 2019-01-25 CN CN201980012323.3A patent/CN111699190A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| ES2916405T3 (es) | 2022-06-30 |
| AU2019218837A1 (en) | 2020-09-24 |
| EP3749673A1 (en) | 2020-12-16 |
| CA3088596C (en) | 2025-06-17 |
| CN111699190A (zh) | 2020-09-22 |
| SI3749673T1 (sl) | 2022-07-29 |
| CA3088596A1 (en) | 2019-08-15 |
| WO2019154634A1 (en) | 2019-08-15 |
| BR112020015217A2 (pt) | 2021-01-26 |
| MX2020008360A (es) | 2020-09-25 |
| EP3749673B1 (en) | 2022-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3810581T3 (da) | Krystalmodifikationer af odevixibat | |
| IL286218A (en) | Solid state forms of ripretinib | |
| DK4045039T3 (da) | Hæmning af human integrin-alfa4beta7 | |
| IL268852A (en) | Crystalline forms of the 4-pyrimidinesulfamide derivative aprocitentan | |
| DK3377059T3 (da) | Hæmmere af cxcr2 | |
| DK3978483T3 (da) | Krystallinsk toluensolvat af (s)-afoxolaner | |
| DK3509581T3 (da) | Formuleringer af (r)-2-amino-3-phenylpropylcarbamat | |
| HUE064559T2 (hu) | MAGL inhibitor kristályos formája | |
| DK3830085T3 (da) | Deutereret derivat af lanifibranor | |
| DK3798222T3 (da) | Krystallinsk form af den frie base af lorlatinib | |
| DK3692039T3 (da) | Enantiomerer af substituerede thiazoler som antivirale forbindelser | |
| DK3807260T3 (da) | Oprensning af nikotin | |
| DK3817751T3 (da) | Formuleringer af vandfrit natriumthiosulfat | |
| DK3943070T3 (da) | Langtidsvirkende formuleringer af bedaquilin | |
| IL269792B (en) | Crystalline forms of (s)-afoxolaner | |
| DK3474822T3 (da) | Formuleringer af brincidofovir | |
| EP3909953A4 (en) | UPADACITINIB SALT COMPOUND AND METHOD FOR PREPARING IT | |
| DK3759745T3 (da) | Dannelse af piezoelektriske anordninger | |
| DK3717503T3 (da) | Albumin-bindende prodrugs af auristatin E derivater | |
| DK3697418T3 (da) | Forbedrede formuleringer af bromocriptin | |
| EP3829551C0 (en) | CRYSTALLINE EPINEPHRINE MALONATE SALT | |
| DK3636640T3 (da) | Krystal af heterocyclidenacetamidderivat | |
| DK3749673T3 (da) | Krystallinsk form af bictegravir-natrium | |
| DK3580197T3 (da) | Oprensning af pleuromutilin | |
| DK3567245T3 (da) | Drift af vindmølle |